Recent Company News

• 02:02 PM ET Aug 03, 2026
  

  StreetAccount Summary - Private Company Weekly Recap - Week of 27-Jul

• 04:24 PM ET Jul 30, 2026
  

  AnaptysBio discloses stipulation proposing schedule governing post-trial briefing in connection with TESARO litigation - 8-K ($55.04, 0.00)

• 10:22 AM ET Jul 29, 2026
  

  ViiV's Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV

• 04:57 PM ET Jul 28, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 01:03 PM ET Jul 28, 2026
  

  Transcript Intelligence: GSK Plc Q2 Earnings Guidance

• 01:03 PM ET Jul 28, 2026
  

  Transcript Intelligence: GSK Plc Q2 Earnings Themes

• 01:03 PM ET Jul 28, 2026
  

  Transcript Intelligence: GSK Plc Q2 Earnings Q&A

• 08:59 AM ET Jul 28, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:26 AM ET Jul 28, 2026
  

  StreetAccount Summary - US Pre-market trading

• 08:17 AM ET Jul 28, 2026
  

  Follow-up: GSK initiates new "Accelerate Growth" programme targeting £1.9B of annual savings, to be fully realised by 2029 (1992.0000p, +30)